Drug Screening Market Insights
North America and Europe areexpected to Dominatethe Drug Screening Market over the forecast period due to presence ofleading manufacturers such as Alere, Inc. Mergers and acquisitions by keyplayers are expected to foster growth of the market such as Abbott Laboratoriesacquisition of Alere, Inc. in 2017. Asia Pacific region is expected to witnesssignificant growth over the forecast period, owing to increasing presence ofleading manufacturers in the region. For instance, Alere Medical Pvt. Ltd.launched integrated facility in India for manufacturing rapid point of carediagnostic devices in 2016. The company intends to make India an export hub forrapid diagnostic devices in Asia Pacific region.
Drug screening involves testingof the samples such as urine, breath, oral fluid, hair, and others for presenceof any substances over the limit. The significance of the drug screening isthat a person under influence of the drugs or alcohol is liable for roadaccidents, and other workplace issues. Manufacturers such as AbbottLaboratories provide drug screening tests for testing purposes at workplace, ingovernment organizations, rehabilitation centers, and other places. These testsare painless and non-invasive. Moreover, manufacturers such as Alere, Inc.(part of Abbott Laboratories) provide point-of-care diagnostic tests for drugscreening. Furthermore, drug addict individuals involved in certain professionssuch as an air traffic controller, and commercial drivers can risk safety ofothers, which can be avoided by pre-employment urine testing. On-the-jobaccidents could also be reduced with the help of drug screening. A urine drugtest is painless and analyzes presence of prescription drugs such asamphetamines, methamphetamines, benzodiazepines, marijuana, barbiturates,cocaine, methadone, and opioids (narcotics). Moreover, drug and alcoholrehabilitation centers need to test residents on a regular basis to ensure thesoberness of the people receiving treatment. Oral fluid testing and breathtesting is conducted to examine presence of alcohol in the body and to ascertainthe level of the same. Technological advancements such as immunoassaytechniques for drug screening, and rapid point of care tests have fosteredgrowth of the drug screening market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1696
Drug Screening Market Drivers
Competition among leadingmanufacturers in the drug screening market is supporting the growth of the drugscreening market. Manufacturers are engaged in developing innovative productsin wide categories in order to maintain leading position in the market. Alere,Inc. along with its partner company GenPrime, Inc., launched point of caretesting device, the xReader for work-place drug testing in 2016. In 2017,Alere, Inc. launched Alere iCup Rx drug screen for detecting commonly misusedand abused prescription drugs. Moreover, technological advancements areexpected to boost growth of the drug screening market over the forecast period.For instance, Intelligent Fingerprinting Limited launched non-invasive portablefingerprint drug test in 2017. Moreover, increasing incidences of trafficaccidents, owing to drunk driving or driving after drug consumption is expectedto boost growth of the drug screening market over the forecast period. Forinstance, five Michigan counties launched pilot roadside drug testing in November2017, which used Alere DDS2 oral fluid test instrument to detect marijuana,opioids, and other drugs. Moreover, Captiva Lab launched an oral fluid drugtesting integrated with mass spectrometry to include an oral fluid test panelin 2017. Furthermore, increasing demand from vast number of places where drugscreening may be required such as workplace, hospitals, and rehabilitationcenters is expected to boost growth of the drug screening market over theforecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/drug-screening-market-1696
Phenomenex, Inc. launched Strata-X-DrugB Plus a solid phase extraction (SPE) sample preparation product for urine drugtesting in May 2018.
However, ban of alcohol and drugsat workplace and government organizations, and increasing awareness againstdriving under influence is expected to hinder the growth of the drug screeningmarket.
Drug Screening Market CompetitiveLandscape
Key players operating in theglobal drug screening market include Thermo Fisher Scientific, QuestDiagnostics, Omega Laboratories, Abbott Laboratories, Danaher Corporation,Express Diagnostics International Inc., Siemens Healthineers, Alfa ScientificDesigns, F. Hoffmann La Roche, SureHire, and OraSure.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1696
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200 Seattle,WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
